There are no 'ifs'. That is the case. I have got that information from the results presentation (but I estimated the percentages - attached are the actual percentages). The loss was mainly for one off items. I have attached the 2 most important graphs in my opinion on the presentation. As you can see, once interstate travel opened, the OTA revenue was nearing breakeven point. On the B2B business side, we are far off from breaking even but the trend is very very good. They are losing 11m per month and have said they can last like this till the end of 2021. In all likelyhood, interstate travel in Australia will be open before the end of 2020. This means we will be breaking even on the OTA by the end of this year. If the Oxford vaccine trial is successful, most of Australia will be vaccinated early 2021 which means travel interstate will return to precovid levels and the B2B part of the business will become profitable again. B2B looks like it might near breakeven even without a vaccine provided the trend in the chart continues.
WEB Price at posting:
$3.43 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)